Octalfa

AI Verified

Location

France


Investor type

Venture Capital


Current investment status

00 00 00


Website

https://octalfa.eu


Linkedin

00 00 00


Submission link

00 00 00


Company address

Chemin du Saquin, Écully, Lyon, Métropole de Lyon, Rhône, Auvergne-Rhône-Alpes, Metropolitan France, 69130, France


Founding year

2007


Twitter

00 00 00


Facebook

00 00 00

Criteria Requirements Match
Regions North America, Western Europe
00
Countries
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Sector
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Impact Area
00 00 00
Stage Seed, Series A, Series B, Growth Stage, Pre-Seed
00
Ticket size
00 00 00
-
00 00 00
USD
00
Monetization model
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Product readiness
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Client types
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Min. revenue
00 00 00
USD
00
Other
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
-

Unlock Free Premium Insights

Discover how well you match with this investor and reach out on the Raise Better platform.

  • Advanced matching algorithm
  • Detailed compatibility scores
  • Priority investor access
Create Free Account

Company description

Octalfa stands as a distinguished independent family enterprise with nearly three decades of dedication to innovation in healthcare and life sciences. Founded by Gilles Alberici, the group has established itself as a significant player in biotechnology, focusing on critical medical domains including pediatric medicine, cancer immunology, advanced diagnostics, and specialized materials development. Their entrepreneurial approach combines scientific expertise with strategic investment vision, creating a unique position in the European biotech investment landscape.

The investment portfolio of Octalfa reflects their deep commitment to transformative healthcare solutions. Their capital allocation strategy prioritizes companies developing breakthrough technologies with potential for substantial clinical impact. With investments spanning early-stage startups to more established biotech firms, Octalfa has cultivated a diverse ecosystem of portfolio companies working on next-generation therapeutics, diagnostic platforms, and medical technologies. Their investment approach typically combines financial support with strategic guidance, leveraging the family's extensive industry connections and scientific expertise to accelerate growth.

Beyond pure financial returns, Octalfa demonstrates a profound commitment to social responsibility through the Dominique & Tom Alberici Foundation and their dedicated endowment fund. Since 2008, these philanthropic initiatives have been fully integrated into the group's core strategy and governance structure. Their humanitarian efforts specifically target support for cancer patients and individuals with disabilities, with a special emphasis on pediatric care. These programs operate primarily in France and Madagascar, reflecting the group's international humanitarian vision while maintaining strong regional connections.

What distinguishes Octalfa in the investment landscape is their holistic approach to value creation. Rather than viewing their portfolio companies as mere financial assets, they foster an ecosystem where scientific innovation, business development, and social impact coexist harmoniously. This philosophy has enabled them to maintain long-term partnerships with researchers, healthcare institutions, and fellow investors across Europe. As the biotech sector continues evolving, Octalfa's combination of family-driven values with sophisticated investment strategies positions them uniquely to support the next generation of healthcare innovations while maintaining their commitment to improving patient outcomes worldwide.

Highlights

Independent family group entrepreneurial in life sciences
Supporting people with cancer or disabilities since 2008

Ready to raise better?

Create your Free Account!

Frequently asked questions

Where is Octalfa located?

Octalfa maintains its global headquarters in France, serving as the strategic center for its operations. The company's primary corporate offices are located at Chemin du Saquin, Écully, Lyon, Métropole de Lyon, Rhône, Auvergne-Rhône-Alpes, Metropolitan France, 69130, France.

What investment stages Octalfa focuses on?

Octalfa focuses its investment activities on companies operating in the following stages: Seed, Series A, Series B, Growth Stage, Pre-Seed. Octalfa provides strategic capital and expertise to support promising businesses at these critical phases of development.

Where does Octalfa invest?

Octalfa maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Western Europe.

When was Octalfa founded?

Octalfa was established in 2007, marking the beginning of its journey as an investment firm.

What kind of investment firm is Octalfa?

Octalfa is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.